Bold Therapeutics Inc.
515-850 W Hastings St V6C1E1 Vancouver, BC, Canada

More exciting news from Bold Therapeutics regarding COVID-19! https://www.prnewswire.com//bold-100-significantly-outperf

New data shows potent antiviral efficacy for BOLD-100 against live SARS-CoV-2 (COVID-19). Exciting! https://www.prnewswire.com//bold-100-demonstrates-nanomola

Bold Therapeutics is excited to expand its COVID-19 consortium to include four additional collaborators from prominent institutions in Canada and the U.K. https://www.prnewswire.com//bold-therapeutics-expands-covi University of British Columbia University of Ottawa Western University University of Oxford

More exciting news for Bold Therapeutics as we partner with Hana Pharm, one of the largest and fastest growing biopharma companies in South Korea, to advance BOLD-100 in the treatment of gastric, pancreatic, colorectal and bile duct cancers! https://www.prnewswire.com//bold-therapeutics-executes-opt

Exciting progress as Bold Therapeutics teams up with one of Canada's leading research universities! https://www.prnewswire.com//bold-therapeutics-and-the-univ

Bold Therapeutics is seeking collaborators for rapid development of BOLD-100, its lead drug candidate with potential utility in the treatment of COVID-19. Visit www.bold-therapeutics.com/COVID-19 for more information! https://lnkd.in/eGRYC8v